![Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet](https://www.thelancet.com/cms/attachment/c4924d20-e441-4daa-adaa-df17582f95e5/gr1_lrg.gif)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet
![Statins may increase diabetes, but benefit still outweighs risk | Cleveland Clinic Journal of Medicine Statins may increase diabetes, but benefit still outweighs risk | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/90/1/53/F3.large.jpg)
Statins may increase diabetes, but benefit still outweighs risk | Cleveland Clinic Journal of Medicine
![Statin use for primary prevention in patients with type 2 diabetes: Can it benefit all ages? – A nationwide propensity-matched cohort study - ScienceDirect Statin use for primary prevention in patients with type 2 diabetes: Can it benefit all ages? – A nationwide propensity-matched cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168822721004034-gr1.jpg)
Statin use for primary prevention in patients with type 2 diabetes: Can it benefit all ages? – A nationwide propensity-matched cohort study - ScienceDirect
![IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights](https://www.mdpi.com/ijms/ijms-21-04725/article_deploy/html/images/ijms-21-04725-g003.png)
IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
![Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study](https://pub.mdpi-res.com/biomedicines/biomedicines-08-00499/article_deploy/html/images/biomedicines-08-00499-ag.png?1605260704)
Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
![Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | Cardiovascular Diabetology | Full Text Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-020-01037-0/MediaObjects/12933_2020_1037_Fig1_HTML.png)
Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study | Cardiovascular Diabetology | Full Text
![Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. | Semantic Scholar Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7d4a46105d0e1898614011a7da68da86f7a56f62/2-Figure1-1.png)
Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. | Semantic Scholar
![Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - The Lancet Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2ba8fb0a-2b81-4743-acd7-25b527fd38f3/gr1.gif)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - The Lancet
![Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/dac8d277-379e-47e5-ab84-580b05e348a4/jah33974-fig-0002.png)
Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association
![IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights](https://pub.mdpi-res.com/ijms/ijms-21-04725/article_deploy/html/images/ijms-21-04725-g006.png?1593757293)